(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Leukemia
This clinical study will evaluate the safety of an experimental drug to treat chronic myeloid leukemia. Volunteers at least 18 with chronic myeloid leukemia who are resistant or intolerant to Imatinib and whose cancer hasn't spread to the central nervous system may be included. Participants also cannot have a history of heart disease.
The research site is in New York City.
More information
Please see http://www.centerwatch.com/patient/studies/cat92.html.
-----
Healthy Patient Studies
Healthy volunteers are needed to participate in a research study of blood platelets. You may be eligible if you are 18 or older, have no history of excessive bleeding or clotting, and have not taken any medications for the ten days prior to the study.
The research site is in Lexington, Ky.
More information
Please see http://www.centerwatch.com/patient/studies/phasei.html.
-----
Sleep Disorders
People who are completely blind and who have difficulty sleeping or maintaining a regular sleep/wake schedule are needed for this clinical study of an investigational medication. Participants must otherwise be in good health. The study consists of four office visits over approximately three months. Financial compensation may be provided.
The research site is in New York City.
More information
Please see http://www.centerwatch.com/patient/studies/cat169.html.
-----
Copyright 2006 Thomson CenterWatch. All rights reserved.
